NewBridge Pharmaceuticals

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Crown Will Offer $924m To Merge With Re

When it comes to reaching markets in the Middle East and North Africa (MENA), global pharmaceutical companies have historically had to contend with fragmented and inefficient systems, stifling their a

BioCryst Pharmaceuticals, Inc. ’s launch numbers for Orladeyo (berotralstat) have beat expectations, and the North Carolina-based firm says its drug – the first oral prophylaxis for hereditary angioed

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. AstraZeneca Offloads Phase III-Ready Su